“Treatment or Psoriasis With Calcipotriene and Betamethasone Dipropionate (CAL BDP) Cream Showed Significantly Higher Proportion of Patients With an Absolute mPASI≤2 Compared to CAL BDP Gel Topical Suspension in a Post-Hoc Aanalysis of Two Phase 3 Studies”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s233. Accessed May 19, 2025. https://skin.dermsquared.com/skin/article/view/2418.